Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1972;39:745-752
© 1972 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MORROW, C. P.
Right arrow Articles by RUTLEDGE, F. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORROW, C. P.
Right arrow Articles by RUTLEDGE, F. N.

Melanoma of the Vulva

CHARLES P. MORROW, MD and FELIX N. RUTLEDGE, MD, FACOG

From the Department of Surgery, Section of Gynecology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston, Tex.

Abstract

Forty patients with vulvar melanoma were registered at the MD Anderson Hospital and Tumor Institute from March 1944 to April 1970. The 30 previously untreated patients were retrospectively staged and the results of treatment evaluated. The gross 5-year survival rate among 14 eligible patients was 50%. Prognosis is related to stage. Clinically positive regional nodes is an ominous finding. Radical vulvectomy and bilateral groin node dissection constitute the minimum treatment. In most cases bilateral pelvic lymphadenectomy should be included. The vaginal-urethral margin of resection is the most frequent point of failure with this management.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by the American College of Obstetricians and Gynecologists.